Balyasny Asset Management’s Verona Pharma VRNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$56.1M	Buy	593,649 +132,420	+29%	+$12.5M	0.08%	232
2025 Q1	$29.3M	Buy	461,229 +277,332	+151%	+$17.6M	0.05%	348
2024 Q4	$8.54M	Buy	+183,897	New	+$8.54M	0.01%	710
2023 Q4	–	Sell	-10,024	Closed	-$163K	–	2310
2023 Q3	$163K	Buy	+10,024	New	+$163K	﹤0.01%	1585